Subscribe To
celldex therapeutics to present at cantor global healthcare conference
HAMPTON, N.J., Sept. 25, 2023 (GLOBE NEWSWIRE) — celldex Therapeutics, Inc. (NASDAQ:CLDX) announced t...
September 25, 2023, 12:31 pm
celldex therapeutics to present at cantor global healthcare conference
HAMPTON, N.J., Sept. 25, 2023 (GLOBE NEWSWIRE) -- celldex Therapeutics, Inc. (NASDAQ:CLDX) announced to...
September 25, 2023, 8:31 am
celldex therapeutics (cldx) reports q2 loss, misses revenue estimates
celldex Therapeutics (CLDX) came out with a quarterly loss of $0.65 per share in line with the Zacks Co...
August 8, 2023, 6:57 pm
celldex therapeutics presents positive data from barzolvolimab chronic urticaria program at eaaci 2023
– Data updates at EAACI 2023 continue to position barzolvolimab as a potential best-in-class addition to a historically limited treatment landscape ...
June 10, 2023, 2:45 pm
celldex therapeutics to present at jefferies healthcare conference
HAMPTON, N.J., June 02, 2023 (GLOBE NEWSWIRE) -- celldex Therapeutics, Inc. (NASDAQ:CLDX) announced tod...
June 2, 2023, 8:01 am
celldex therapeutics presents positive preclinical data from tslp/scf bispecific antibody program cdx-622 at immunology2023™
HAMPTON, N.J., May 15, 2023 (GLOBE NEWSWIRE) — celldex Therapeutics, Inc. (NASDAQ:CLDX) today announc...
May 15, 2023, 12:01 pm
celldex therapeutics (cldx) reports q1 loss, tops revenue estimates
celldex Therapeutics (CLDX) came out with a quarterly loss of $0.62 per share versus the Zacks Consensu...
May 4, 2023, 7:44 pm
Strength seen in celldex (cldx): can its 7.1% jump turn into more strength?
celldex (CLDX) witnessed a jump in share price last session on above-average trading volume. The latest...
April 18, 2023, 7:38 am
celldex therapeutics to present at h.c. wainwright autoimmune & inflammatory disease virtual conference
HAMPTON, N.J., March 29, 2023 (GLOBE NEWSWIRE) -- celldex Therapeutics, Inc. (NASDAQ:CLDX) announced to...
March 29, 2023, 9:01 am
celldex therapeutics presents positive data from barzolvolimab phase 1b study in chronic spontaneous urticaria at aaaai 2023
– Rapid, profound and durable responses across multiple dosing groups with favorable safety profile observed—positioning barzolimab as a potential...
February 26, 2023, 2:00 pm
celldex: long list of failures, high valuation, but good data recently
celldex has failed too many times to inspire confidence. The company's current valuation is also quite ...
February 20, 2023, 5:10 am
celldex therapeutics announces multiple upcoming presentations of barzolvolimab data at ga²len global urticaria forum (guf) 2022
– Includes oral presentation for 1.5 mg/kg cold urticaria cohort – – Company to host webcast conference call on Tuesday, December 6 at 8:00 am E...
December 2, 2022, 2:31 pm
celldex therapeutics (cldx) reports q3 loss, tops revenue estimates
celldex (CLDX) delivered earnings and revenue surprises of 0% and 62.80%, respectively, for the quarter...
November 9, 2022, 6:48 pm
celldex: barzolvolimab plus bispecific antibodies advancement
Proof of concept has been established in using Barzolvolimab in treating Chronic spontaneous urticaria and Chronic inducible urticaria patients in pha...
July 14, 2022, 3:32 pm
Read how cantor views celldex therapeutics' barzolvolimab data
celldex Therapeutics Inc's (NASDAQ: CLDX) shares closed almost 16% down on Friday after releasing Pha...
July 5, 2022, 4:01 pm
celldex (cldx) down on interim data from phase ib study in csu
celldex (CLDX) posts interim data from the phase Ib study evaluating barzolvolimab in patients with mod...
July 4, 2022, 1:12 pm
celldex therapeutics (cldx) reports q1 loss, misses revenue estimates
celldex (CLDX) delivered earnings and revenue surprises of -6.52% and 76.80%, respectively, for the qua...
May 5, 2022, 7:34 pm
celldex therapeutics, inc. (cldx) ceo anthony marucci on q4 2021 results - earnings call transcript
celldex Therapeutics, Inc. (CLDX) CEO Anthony Marucci on Q4 2021 Results - Earnings Call Transcript...
February 28, 2022, 8:57 pm
celldex therapeutics, inc. (cldx) ceo anthony marucci on q4 2021 results - earnings call transcript
celldex Therapeutics, Inc. (CLDX) CEO Anthony Marucci on Q4 2021 Results - Earnings Call Transcript...
February 28, 2022, 8:57 pm
celldex therapeutics, inc. (cldx) ceo anthony marucci on q4 2021 results - earnings call transcript
celldex Therapeutics, Inc. (CLDX) CEO Anthony Marucci on Q4 2021 Results - Earnings Call Transcript...
February 28, 2022, 8:57 pm